Lotus Eye Hospital & Institute (BOM:532998) Dividend Yield %: 0.00% (As of Jul. 01, 2026)


BOM:532998 Lotus Eye Hospital & Institute Ltd BOM:532998
67 GF Score
Price ₹116.85
GF Value ₹91.85
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Lotus Eye Hospital & Institute Dividend Yield %?

Lotus Eye Hospital & Institute BOM:532998 -4.38% 67 Dividend Yield % is 0.00% as of Jul. 01, 2026. GuruFocus rates BOM:532998 with a GF Score™ of 67/100 and a GF Value™ of ₹91.85 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 281 Healthcare Providers & Services companies, Lotus Eye Hospital & Institute ranks worse than 355871.53% on this metric.

As of today (2026-07-01), the Trailing Annual Dividend Yield of Lotus Eye Hospital & Institute is 0.00%.

The historical rank and industry rank for Lotus Eye Hospital & Institute's Dividend Yield % or its related term are showing as below:

During the past 13 years, the highest Dividend Yield of Lotus Eye Hospital & Institute was 2.94%. The lowest was 0.00%. And the median was 0.93%.

BOM:532998's Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.37
* Ranked among companies with meaningful Dividend Yield % only.

Lotus Eye Hospital & Institute's Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of Lotus Eye Hospital & Institute was 1.17. The lowest was 0.26. And the median was 0.36.

As of today (2026-07-01), the Forward Dividend Yield % of Lotus Eye Hospital & Institute is 0.00%.

Lotus Eye Hospital & Institute's Dividends per Share for the three months ended in Mar. 2026 was ₹0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Lotus Eye Hospital & Institute  (BOM:532998) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Lotus Eye Hospital & Institute Dividend Yield % Related Terms


Lotus Eye Hospital & Institute Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Lotus Eye Hospital & Institute's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Eye Hospital & Institute Dividend Yield % Chart

Lotus Eye Hospital & Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 0.86 0.88 0.00 0.00

Lotus Eye Hospital & Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:532998 vs HCA, THC, DVA: Dividend Yield % Comparison

For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Eye Hospital & Institute Dividend Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Lotus Eye Hospital & Institute's Dividend Yield % falls into.


BOM:532998
67GF Score
Lotus Eye Hospital & Institute Ltd BOM:532998
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lotus Eye Hospital & Institute Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Lotus Eye Hospital & Institute (BOM:532998) has a Dividend Yield % of 0.00% as of Jul. 01, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Lotus Eye Hospital & Institute and its competitors. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #999999 out of 281 companies in the Healthcare Providers & Services industry.
Is Lotus Eye Hospital & Institute's Dividend Yield % too high?
Lotus Eye Hospital & Institute's current Dividend Yield % is 0.00%. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #999999 out of 281 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's Dividend Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #999999 out of 281 companies for Dividend Yield %. This places Lotus Eye Hospital & Institute in the lower half of its industry. The industry median Dividend Yield % is 2.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.37, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹91.85, compared to a current price of ₹116.85 — trading 27.2% above its estimated fair value. The current Dividend Yield % is 0.00%. Lotus Eye Hospital & Institute's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current Dividend Yield % is 0.00% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued. The current stock price of ₹116.85 is trading 27.2% above its estimated GF Value™ of ₹91.85. GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.

Key valuation signals for BOM:532998:

  • Dividend Yield %: 0.00%
  • GF Value™: ₹91.85 vs. price of ₹116.85 (27.2% above fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lotus Eye Hospital & Institute Business Description

Other Exchanges LOTUSEYE:India
Address SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
67GF Score

Get the complete analysis for BOM:532998

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹116.85
Price
₹91.85
GF Value